Opatrný K
I. interní klinika LF UK, Plzen.
Vnitr Lek. 1996 Dec;42(12):818-24.
Methods of continuous renal replacement therapy are used to an increasing extent also in this country. The oldest one, continuous arteriovenous haemofiltration has been supplemented by continuous haemodialysis, hemodiafiltration and high-flux dialysis. An alternative of the arteriovenous vascular access is the veno-venous one. Indication for continuous renal replacement therapy are patients with acute renal failure in a critical condition, i.e. in particular patients with acute renal failure as part of multiorgan failure and patients with an unstable circulation. In this indication methods of continuous renal replacement therapy were accepted due to their effective and safe character. Moreover so far evidence was not yet provided that continuous methods lead to longer survival of patients with acute renal failure than intermittent dialysis or other intermittent methods of renal replacement therapy. So far it has not been proved that continuous methods are an asset in the treatment of conditions such as sepsis/septic shock, necrotizing pancreatitis, syndrome of acute respiratory distress (ARDS) and others, if the renal function is preserved. Problems of indication and comparison with intermittent procedures must be resolved in subsequent well planned studies. Problems which must be dealt with in future are technical innovations which will increase the effectiveness of the procedures, e.g. by making fuller use of adsorption, and problems of hemocompatibility, in particular in relation to the thrombogenicity of the extracorporeal circulation and the associated administration of anti-thrombotic drugs.
在这个国家,持续肾脏替代治疗方法的使用范围也在不断扩大。最古老的方法,即持续动静脉血液滤过,已被持续血液透析、血液透析滤过和高通量透析所补充。动静脉血管通路的一种替代方式是静脉-静脉通路。持续肾脏替代治疗的适应症是处于危急状态的急性肾衰竭患者,即特别是作为多器官功能衰竭一部分的急性肾衰竭患者以及循环不稳定的患者。由于其有效性和安全性,持续肾脏替代治疗方法在这种适应症中被接受。此外,到目前为止,尚无证据表明持续治疗方法能使急性肾衰竭患者的生存期比间歇性透析或其他间歇性肾脏替代治疗方法更长。到目前为止,尚未证明在肾功能正常的情况下,持续治疗方法在治疗败血症/脓毒性休克、坏死性胰腺炎、急性呼吸窘迫综合征(ARDS)等病症时是一种优势。适应症问题以及与间歇性治疗方法的比较问题必须在后续精心规划的研究中得到解决。未来必须解决的问题包括技术创新,例如通过更充分地利用吸附作用来提高治疗效果,以及血液相容性问题,特别是与体外循环的血栓形成性以及相关抗血栓药物的使用有关的问题。